<scp>AOSNP</scp> ‐ <scp>ADAPTR</scp> resource level‐based recommendations on practical diagnostic strategies for <scp>WHO CNS5</scp> adult‐type diffuse gliomas

The fifth edition of the WHO classification of CNS Tumors (WHO CNS5) has revised the diagnostic and grading criteria for Adult-type Diffuse Gliomas (ADGs) by integrating molecular parameters with histologic features. Conducting molecular testing for most ADGs is now crucial in fulfilling the WHO CNS5 diagnostic criteria. However, due to additional costs and technical barriers, implementing molecular diagnostics is often not feasible in Low-Income Countries (LICs) and Lower Middle-Income Countries (LMICs). Therefore, practical approaches are needed for diagnosis in resource-restrained settings. Hence, the Asian Oceanian Society of Neuropathology (AOSNP), through the 'ADAPTR' (Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions) initiative, aimed to provide resource-stratified recommendations for diagnosing ADGs based on available resources while adhering to the WHO guidelines as much as possible. ADAPTR identified different resource levels (RLs) of diagnostic pathology services, ranging from RL I to RL V, with RL I to RL IV being applicable to the LMICs, and provides recommendations for a 'Histology-oriented integrated diagnosis format' for each tumor type at different RLs. In addition, diagnostic flow charts for ADGs have been generated to suit these RLs. The emphasis is mainly on using histopathological approaches with immunohistochemistry, while molecular testing recommendation is categorized as 'can be considered', 'highly recommended' or 'obligatory', to reach the next level diagnosis. In each RL, either a WHO CNS5 diagnosis with an accompanying CNS WHO grade or an ADAPTR descriptive diagnosis with an associated ADAPTR histologic grade is provided, depending on the context. ADAPTR recommendations are therefore a practical adaptation of the WHO CNS5 guidelines that will suit routine diagnostic practices in resource-restrained regions.

Authors

Institutions

Publication Details

Journal
Brain Pathology
Published
2025-10-26
DOI
https://doi.org/10.1111/bpa.70046
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AOSNP ‐ ADAPTR resource level‐based recommendations on practical diagnostic strategies for WHO CNS5 adult‐type diffuse gliomas

Maysa A. Al-Hussaini, Junji Shibahara, Vani Santosh, Shilpa Rao et al.
Brain Pathology
Glioma Diagnosis and Treatment
article

AOSNP ‐ ADAPTR resource level‐based recommendations on practical diagnostic strategies for WHO CNS5 adult‐type diffuse gliomas

Maysa A. Al-Hussaini, Junji Shibahara, Vani Santosh, Shilpa Rao, Pieter Wesseling, Sung‐Hye Park, Michael E. Buckland, Tarık Tihan, Chitra Sarkar, Ho‐Keung Ng, Takashi Komori, David N. Louis
article en

Abstract

The fifth edition of the WHO classification of CNS Tumors (WHO CNS5) has revised the diagnostic and grading criteria for Adult-type Diffuse Gliomas (ADGs) by integrating molecular parameters with histologic features. Conducting molecular testing for most ADGs is now crucial in fulfilling the WHO CNS5 diagnostic criteria. However, due to additional costs and technical barriers, implementing molecular diagnostics is often not feasible in Low-Income Countries (LICs) and Lower Middle-Income Countries (LMICs). Therefore, practical approaches are needed for diagnosis in resource-restrained settings. Hence, the Asian Oceanian Society of Neuropathology (AOSNP), through the 'ADAPTR' (Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions) initiative, aimed to provide resource-stratified recommendations for diagnosing ADGs based on available resources while adhering to the WHO guidelines as much as possible. ADAPTR identified different resource levels (RLs) of diagnostic pathology services, ranging from RL I to RL V, with RL I to RL IV being applicable to the LMICs, and provides recommendations for a 'Histology-oriented integrated diagnosis format' for each tumor type at different RLs. In addition, diagnostic flow charts for ADGs have been generated to suit these RLs. The emphasis is mainly on using histopathological approaches with immunohistochemistry, while molecular testing recommendation is categorized as 'can be considered', 'highly recommended' or 'obligatory', to reach the next level diagnosis. In each RL, either a WHO CNS5 diagnosis with an accompanying CNS WHO grade or an ADAPTR descriptive diagnosis with an associated ADAPTR histologic grade is provided, depending on the context. ADAPTR recommendations are therefore a practical adaptation of the WHO CNS5 guidelines that will suit routine diagnostic practices in resource-restrained regions.

Brain PathologyVol. 36(2)
Brigham and Women's Hospital (US), Harvard University (US), Seoul National University (KR), University of Miami (US), Chinese University of Hong Kong (HK), Kyorin University (JP), King Hussein Cancer Center (JO), Royal Prince Alfred Hospital (AU), New Generation University College (ET), Massachusetts General Hospital (US), Tokyo Metropolitan Neurological Hospital (JP), Princess Máxima Center (NL), Amsterdam University Medical Centers (NL), All India Institute of Medical Sciences (IN), National Institute of Mental Health and Neurosciences (IN), Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Indian National Science Academy
Openalex Percentile: Top 58%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.